Email this pageWelcome
The University of Rochester Clinical and Translational Science Institute is one of 12 institutions nationwide with funding from the National Institutes of Health to lead the emerging field of clinical and translational research. The Institute is building the foundation to assist researchers at the UR and across Upstate New York to produce innovative technology and methods that more efficiently and more quickly advance treatments to patients.
"We have been piecing together the building blocks for clinical and translational science at the School of Medicine over my entire time as dean," said David Guzick, M.D., Ph.D., Dean of the School of Medicine since 2002 and Principal Investigator for the NIH project. "We share a common vision with NIH that there should be an academic home for such research. Our Institute is the next logical step in this area of investigation.
"The University of Rochester and the School of Medicine increasingly will be known as one of the places for conducting translational research and for training successful academic researchers," said Guzick, who is Director of the Institute.
The goals of the Institute include: increased funds for pilot projects and faculty training; enhanced services for data management, computer simulation, biostatistics, epidemiology, research ethics, and community involvement; new Master's and Doctoral degree programs in clinical and translational science; and the formation of a network of hospitals and biomedical research institutions in Upstate New York whose members will collaborate on projects and share resources.